Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Communication Between Infectious Disease Physicians and US State and Local Public Health Agencies: Strengths, Challenges, and Opportunities.

Santibañez S, Polgreen PM, Beekmann SE, Cairns C, Filice GA, Layton M, Hughes JM.

Public Health Rep. 2016 Sep;131(5):666-670. doi: 10.1177/0033354916660083. Epub 2016 Aug 22.

2.

Preexisting Chronic Health Conditions and Health Insurance Status Associated With Vaccine Receipt Among Adolescents.

Seib K, Underwood NL, Gargano LM, Sales JM, Morfaw C, Weiss P, Murray D, Vogt TM, DiClemente RJ, Hughes JM.

J Adolesc Health. 2016 Feb;58(2):148-53. doi: 10.1016/j.jadohealth.2015.10.009. Epub 2015 Dec 10.

PMID:
26683985
3.

Assessment of Arbovirus Surveillance 13 Years after Introduction of West Nile Virus, United States.

Hadler JL, Patel D, Nasci RS, Petersen LR, Hughes JM, Bradley K, Etkind P, Kan L, Engel J.

Emerg Infect Dis. 2015 Jul;21(7):1159-66. doi: 10.3201/eid2107.140858.

4.

Influence of sources of information about influenza vaccine on parental attitudes and adolescent vaccine receipt.

Gargano LM, Underwood NL, Sales JM, Seib K, Morfaw C, Murray D, DiClemente RJ, Hughes JM.

Hum Vaccin Immunother. 2015;11(7):1641-7. doi: 10.1080/21645515.2015.1038445.

5.

School-Located Vaccination Clinics for Adolescents: Correlates of Acceptance Among Parents.

Gargano LM, Weiss P, Underwood NL, Seib K, Sales JM, Vogt TM, Rask K, Morfaw C, Murray DL, DiClemente RJ, Hughes JM.

J Community Health. 2015 Aug;40(4):660-9. doi: 10.1007/s10900-014-9982-z.

PMID:
25528325
6.

National capacity for surveillance, prevention, and control of West Nile virus and other arbovirus infections--United States, 2004 and 2012.

Hadler JL, Patel D, Bradley K, Hughes JM, Blackmore C, Etkind P, Kan L, Getchell J, Blumenstock J, Engel J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Apr 4;63(13):281-4.

7.

CDC Grand Rounds: discovering new diseases via enhanced partnership between public health and pathology experts.

Zaki S, Blau DM, Hughes JM, Nolte KB, Lynfield R, Carr W, Popovic T; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Feb 14;63(6):121-6.

8.

Development, theoretical framework, and evaluation of a parent and teacher-delivered intervention on adolescent vaccination.

Gargano LM, Herbert NL, Painter JE, Sales JM, Vogt TM, Morfaw C, Jones LM, Murray D, DiClemente RJ, Hughes JM.

Health Promot Pract. 2014 Jul;15(4):556-67. doi: 10.1177/1524839913518222. Epub 2014 Jan 17.

9.

Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines.

Gargano LM, Herbert NL, Painter JE, Sales JM, Morfaw C, Rask K, Murray D, DiClemente RJ, Hughes JM.

Hum Vaccin Immunother. 2013 Dec;9(12):2627-33. doi: 10.4161/hv.25823. Epub 2013 Jul 24.

10.

Understanding reasons for participating in a school-based influenza vaccination program and decision-making dynamics among adolescents and parents.

Herbert NL, Gargano LM, Painter JE, Sales JM, Morfaw C, Murray D, Diclemente RJ, Hughes JM.

Health Educ Res. 2013 Aug;28(4):663-72. doi: 10.1093/her/cyt060. Epub 2013 May 30.

11.

Southeastern Center for Emerging Biologic Threats tabletop exercise: foodborne toxoplasmosis outbreak on college campuses.

Morris JG Jr, Greenspan A, Howell K, Gargano LM, Mitchell J, Jones JL, Potter M, Isakov A, Woods C, Hughes JM.

Biosecur Bioterror. 2012 Mar;10(1):89-97. doi: 10.1089/bsp.2011.0040. Epub 2012 Jan 27.

12.

Rural parents' vaccination-related attitudes and intention to vaccinate middle and high school children against influenza following educational influenza vaccination intervention.

Sales JM, Painter JE, Pazol K, Gargano LM, Orenstein W, Hughes JM, DiClemente RJ.

Hum Vaccin. 2011 Nov;7(11):1146-52. doi: 10.4161/hv.7.11.17891. Epub 2011 Nov 1.

13.

Multicomponent interventions to enhance influenza vaccine delivery to adolescents.

Gargano LM, Pazol K, Sales JM, Painter JE, Morfaw C, Jones LM, Weiss P, Buehler JW, Murray DL, Wingood GM, Orenstein WA, DiClemente RJ, Hughes JM.

Pediatrics. 2011 Nov;128(5):e1092-9. doi: 10.1542/peds.2011-0453. Epub 2011 Oct 10.

14.

Correlates of 2009 H1N1 influenza vaccine acceptability among parents and their adolescent children.

Painter JE, Gargano LM, Sales JM, Morfaw C, Jones LM, Murray D, DiClemente RJ, Hughes JM.

Health Educ Res. 2011 Oct;26(5):751-60. doi: 10.1093/her/cyr025. Epub 2011 May 2.

15.

Seasonal and 2009 H1N1 influenza vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination among secondary school teachers and staff.

Gargano LM, Painter JE, Sales JM, Morfaw C, Jones LM, Murray D, Wingood GM, DiClemente RJ, Hughes JM.

Hum Vaccin. 2011 Jan 1;7(1):89-95. Epub 2011 Jan 1.

16.

Factors influencing emerging infectious diseases in the southeastern United States.

Gargano LM, Schreier B, Hughes JM.

Emerg Infect Dis. 2010 Apr;16(4):e1. No abstract available.

17.

Healthcare infections associated with care and treatment of humans and animals.

Gibson JJ, Kainer MA, Raskin SE, Weber DJ, Orenstein WA, Hughes JM.

Emerg Infect Dis. 2008 Dec;14(12):e1. doi: 10.3201/eid1412.081207. No abstract available.

18.

Increased oxidant activity mediates vascular dysfunction in vibration injury.

Hughes JM, Wirth O, Krajnak K, Miller R, Flavahan S, Berkowitz DE, Welcome D, Flavahan NA.

J Pharmacol Exp Ther. 2009 Jan;328(1):223-30. doi: 10.1124/jpet.108.144618. Epub 2008 Oct 27.

19.

SARS: an emerging global microbial threat.

Hughes JM.

Trans Am Clin Climatol Assoc. 2004;115:361-72; discussion 372-4. Review.

20.

Emerging infectious determinants of chronic diseases.

O'Connor SM, Taylor CE, Hughes JM.

Emerg Infect Dis. 2006 Jul;12(7):1051-7.

Supplemental Content

Loading ...
Support Center